<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="462">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03100851</url>
  </required_header>
  <id_info>
    <org_study_id>CAUConstipation-01</org_study_id>
    <nct_id>NCT03100851</nct_id>
  </id_info>
  <brief_title>Effect of Probiotic on Constipation With Diverse Stool Consistency</brief_title>
  <official_title>Effect of Lactobacillus Casei Strain Shirota on Constipation With Diverse Stool Consistency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>China Agricultural University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China Agricultural University</source>
  <brief_summary>
    <textblock>
      Constipation of different etiology might respond differently to probiotic intervention.
      Lactobacillus casei strain Shirota (LcS) is a well-studied probiotic which effectively
      alleviate constipation. Constipation subjects were recruited according to ROME Ⅲ criteria.
      According to Bristol Stool Form Scale (BS), subjects were divided into 3 groups: hard stool
      (HS, BS&lt;3), normal stool (NS, 3≤BS≤4) and soft stool (SS, 4&lt;BS&lt;5). Subjects consumed 100mL
      per day of a probiotic beverage containing 1.0 × 108 CFU/mL of LcS for 28 days. The change
      in stool consistency was measured as primary outcome. The stool short chain fatty acid and
      gut microbiota were also assessed.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2, 2015</start_date>
  <completion_date type="Actual">November 17, 2016</completion_date>
  <primary_completion_date type="Actual">September 26, 2015</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in stool consistency</measure>
    <time_frame>4 weeks</time_frame>
    <description>Stool consistency accessed by Britol Stool Form Scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in stool short chain fatty acid content</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in gut microbiota</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">47</enrollment>
  <condition>Constipation</condition>
  <arm_group>
    <arm_group_label>Hard Stool</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with hard stool (accessed by Bristol Stool Form Scale, average score &lt; 3) received dietary supplement with Lactobacaiilus casei strain Shirota.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Stool</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients with normal stool (accessed by Bristol Stool Form Scale, average score between 3 and 4) received dietary supplement with Lactobacaiilus casei strain Shirota.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Soft Stool</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients with Soft stool (accessed by Bristol Stool Form Scale, average score &gt; 4)received dietary supplement with Lactobacaiilus casei strain Shirota.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactobacillus casei strain Shirota</intervention_name>
    <description>a bottle of 100 mililiter probiotic diary beverage containing 10^8 CFU Lactobacillus casei strain Shirota every day after lunch.</description>
    <arm_group_label>Hard Stool</arm_group_label>
    <arm_group_label>Normal Stool</arm_group_label>
    <arm_group_label>Soft Stool</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  meet ROME Ⅲ criteria for functional constipation

          -  normal body mass index between 18.5 and 29.9

        Exclusion Criteria:

          -  had a serious disease;

          -  used systemic antibiotics or antimycotics medication and antidiarrheal or laxative
             medication in the 30 days prior to the study;

          -  allergic to milk protein;

          -  constipated because of organic or neurological lesions;

          -  participated in any other studies within 2 months prior to this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Chu H, Zhong L, Li H, Zhang X, Zhang J, Hou X. Epidemiology characteristics of constipation for general population, pediatric population, and elderly population in china. Gastroenterol Res Pract. 2014;2014:532734. doi: 10.1155/2014/532734. Epub 2014 Oct 16. Review.</citation>
    <PMID>25386187</PMID>
  </reference>
  <reference>
    <citation>Sandler RS, Drossman DA. Bowel habits in young adults not seeking health care. Dig Dis Sci. 1987 Aug;32(8):841-5.</citation>
    <PMID>3608732</PMID>
  </reference>
  <reference>
    <citation>Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997 Sep;32(9):920-4.</citation>
    <PMID>9299672</PMID>
  </reference>
  <reference>
    <citation>Tigchelaar EF, Bonder MJ, Jankipersadsing SA, Fu J, Wijmenga C, Zhernakova A. Gut microbiota composition associated with stool consistency. Gut. 2016 Mar;65(3):540-2. doi: 10.1136/gutjnl-2015-310328. Epub 2015 Aug 14.</citation>
    <PMID>26276682</PMID>
  </reference>
  <reference>
    <citation>Khalif IL, Quigley EM, Konovitch EA, Maximova ID. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Dig Liver Dis. 2005 Nov;37(11):838-49. Epub 2005 Oct 5.</citation>
    <PMID>16169298</PMID>
  </reference>
  <reference>
    <citation>Husebye E, Hellström PM, Sundler F, Chen J, Midtvedt T. Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol. 2001 Mar;280(3):G368-80.</citation>
    <PMID>11171619</PMID>
  </reference>
  <results_reference>
    <citation>Dimidi E, Christodoulides S, Fragkos KC, Scott SM, Whelan K. The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2014 Oct;100(4):1075-84. doi: 10.3945/ajcn.114.089151. Epub 2014 Aug 6. Review.</citation>
    <PMID>25099542</PMID>
  </results_reference>
  <results_reference>
    <citation>Koebnick C, Wagner I, Leitzmann P, Stern U, Zunft HJ. Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol. 2003 Nov;17(11):655-9.</citation>
    <PMID>14631461</PMID>
  </results_reference>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 29, 2017</lastchanged_date>
  <firstreceived_date>March 29, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>China Agricultural University</investigator_affiliation>
    <investigator_full_name>Fazheng Ren</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
